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Abstract
We report a case of a 15-year-old boy with autoimmune hepatitis lacking common serologic markers and normal 
gammaglobulinemia associated with immune thrombocytopenia and family history of psoriasis. He presented to our 
department with a 4-year history of a cervical posterior lymphadenopathy and recent petechiae. Previous laboratory 
results 6 months before already showed hepatocellular injury. After exclusion of other causes, the diagnosis of 
autoimmune hepatitis was made based on clinical grounds, associated immune disorder and histological features of 
liver biopsy.
The authors alert for this atypical presentation of autoimmune hepatitis and associated immune thrombocytopenia.
Background
Autoimmune hepatitis is a chronic necroinflamatory liver
disorder often associated with other autoimmune dis-
eases, like rheumatoid arthritis, Sjögren syndrome,
chronic thyroiditis, ulcerative colitis, celiac disease or
others. Association with immune thrombocytopenic pur-
pura is unusual, especially in children [1]. We report a 15-
year-old-boy with a family history of psoriasis, who pre-
sented with cervical lymphadenopathy, severe immune
thrombocytopenia and chronic active autoimmune hepa-
titis successfully treated with prednisolone and azatio-
prine.
Case Presentation
A 15-year-old caucasian boy presented to our emergency
department with a 4-year history of a posterior left cervi-
cal lymphadenopathy and petechiae in his legs that
appeared 2 days before.
Four years before the admission he noted a lump in the
left posterior triangle of his neck, measuring about 1.5
cm of diameter, no tender and without inflammatory
signs. At that time he had no fever or other symptoms.
The cervical echography showed an ovoid shaped lymph-
adenopathy of 21 mm in the posterior cervical left trian-
gle of the neck and laboratory evaluation revealed a
normal blood count and normal levels of liver enzymes.
The serologic testing for Epstein Barr virus yielded a pos-
itive result for past infection (IgM to the viral capsid anti-
gen negative, IgG to the viral capsid antigen positive) as
did for rubella virus (IgM antibody negative, IgG anti-
body positive, he had been vaccinated).
The boy kept asymptomatic, except for lymphadenopa-
thy, and 5 months before the admission he repeated labo-
ratory tests and cervical echography. The left posterior
cervical lymphadenopathy didn't show any change in size
and there was no abnormality in cells blood counts, but
the chemistry panel demonstrated an elevation of serum
alanine aminotransferase (256 UI/L (normal (NR) 10-34
U/L)), serum aspartate aminotransferase (123 UI/L (NR
10-44 U/L)), with normal serum alkaline phosphate (311
UI/L (NR 45-122 U/L)) and lactic dehydrogenase (318
UI/L (NR 240-480 U/L)).
Two days before admission the boy noted petechiae in
his legs and after being attended by his primary care phy-
sician, he was instructed to come to our emergency
department.
Past medical history was remarkable for recurrent
media otitis and mastoiditis at the age of 5, followed by
adenoidectomy and myringotomy with 6 years old and
asthma (not medicated and without exacerbations in the
last year). He had no history of drug allergies nor blood
transfusion and was not taking any medications or drink-
ing alcohol. His immunizations were up to date. His
mother and three uncles have psoriasis. His social history
was unremarkable.
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distress and without jaundice. His vital signs were nor-
mal. No physical signs of chronic or acute liver disease
were found, and the remaining examination was normal,
except for petechiae in his legs and an ovoid shaped cer-
vical posterior lymphadenopathy of approximately 2 cm
in diameter, rubbery consistency, no tender and without
external inflammatory signs. No other lymphadenopathy
or hepatosplenomegaly were found.
Laboratory results included: hemoglobin 14.5 g/dL,
white blood cell count 7.60 × 109/L (42.0% neutrophils,
2.4% eosinophils (182/μL)), platelet count 6 × 109/L, C
reactive protein 0.34 mg/L, aspartate aminotransferase
820 UI/L (NR 10-44 U/L), alanine aminotransferase 1568
UI/L (NR 10-34 U/L), gamma glutamyl transferase 84 UI/
L (NR 11-50 U/L), alkaline phosphate 223 UI/L (NR 45-
122 U/L), total bilirubin 1.10 mg/dL (NR 0.2-1.0 mg/dL),
unconjugated bilirubin 0.17 mg/dL (NR < 0.3 mg/dL),
activated partial thromboplastin time 35.7 s (NR 25.0-
35.0s) prothrombin time 15.4s (NR 8.0-14.0) (Interna-
tional Normalized Ratio 1.30), albumin 4.5 g/dL (NR 3.5-
5.2 g/dL), immunoglobulin G 1240 mg/dL(NR < 1550
mg/dL), ferritin 1230 ng/mL (NR 20-300 ng/mL). He was
heterozygous for the H63D mutation of the HFE gene.
Ceruplasmin, copper and alpha-1-antitrypsin levels were
normal. Viral serologies: Hepatitis A antibody IgM and
IgG negative, Hepatitis B surface antigen negative, Hepa-
titis B core antibody negative, Hepatitis B e antigen and
antibody negatives, Hepatitis B surface antibody negative,
Hepatitis C antibody negative and HIV I/II antibodies
negatives. Epstein Barr Virus (IgM to the viral capsid
antigen negative, IgG to the viral capsid antigen positive,
IgM to the early antigen negative, and antibody to EBNA
positive) and Cytomegalovirus (CMV IgM antibody neg-
ative, CMV IgG positive) serologic results showed past
infection. Testing for antinuclear, antimitochondrial,
anti-smooth muscle, and liver/kidney microssomal anti-
bodies were negative. Abdominal ultrasound showed a
normal homogeneous echo texture of liver and a normal
spleen size of 11 cm.
Liver biopsy was done when the patient had 63 × 109/L
platelets (5 days after admission), and revealed an inflam-
matory lymphocytic infiltrate in portal areas with eosino-
phils. Some areas showed interface hepatitis ("piecemeal
necrosis") with inflammatory lymphocytic infiltrate erod-
ing the limiting plate of hepatocytes and bridging fibrosis
with porto-portal fibrous septa and fibrous in the peri-
portal area. Bile ducts were normal.
Blood smear, bone marrow aspirate and flow cytometry
of peripheral blood cells were negative for neoplasic cells
and pointed to peripheral destruction of platelets cells
with increased number of megakaryocytes in bone mar-
row and rare but big platelets in blood smear. Anti-plate-
let antibodies, detected by flow cytometry, were positive:
IgG 4.32 AU(immunofluorescence arbitrary unit, normal
< 0.33 AU); IgM 0.39 UA (normal < 0.29 AU).
Based on all results we establish the diagnosis of
immune thrombocytopenia and autoimmune hepatitis
with negative serologic markers.
The patient was initially treated with intravenous
immunoglobulin for thrombocytopenia with a partial
response and then with prednisolone. He started azathio-
prine after the diagnosis of autoimmune hepatitis.
He has been followed by about two years and has been
medicated with azathioprine (1.4 mg/kg/day). After 2
months of the admission, platelets count recovered to 96
× 109/L and lymphadenopathy decreased and disap-
peared in the next months. After 10 months platelet
count was normal 158 × 109/L. Liver enzymes returned to
normal after 2 months, aspartate aminotransferase 15 UI/
L (NR 10-44 U/L), alanine aminotransferase 18 UI/L (NR
10-34 U/L), gamma glutamyl transferase 44 UI/L (NR 11-
50 U/L).
Discussion
Autoimmune hepatitis (AIH) is a chronic and progressive
necroinflammatory and fibrotic process of the liver of
unknown cause that occurs in children and adults, usu-
ally associated with the presence of autoantibodies and
hypergammaglobulinemia[2].
It has been described two main types of autoimmune
hepatitis based on differences in autoantibody patterns.
AIH type I is characterized by the presence of circulating
anti-smooth muscle antibodies (SMA) and/or antinuclear
antibodies (ANA) and AIH type II is characterized by cir-
culating liver-kidney microssomal type I antibody (LKM)
or anti-liver cytosol antibody (LCA) [2,3]. Eighty percent
of patients with AIH type II are children.
The diagnosis is made regarding clinical and biochemi-
cal findings of hepatitis and associated autoimmune dis-
eases, abnormal levels of immunoglobulin G, the
presence of the characteristic autoimmune antibodies
and finally, the most important, the histological typical
abnormalities [2,4].
The International Autoimmune Hepatitis Group pro-
posed a scoring system to standardize the diagnosis, use-
ful for clinical trials, but that may be inaccurate in
individual cases, especially in children [2,5].
After excluding viral, toxic and hereditary aetiologies
for hepatitis, in the presence of another autoimmune dis-
ease and considering liver biopsy characteristics, the
most probable cause for hepatitis in our patient was cer-
tainly an autoimmune process. Nevertheless, we didn't
find the common serologic markers of this disease (SMA,
ANA, LKM and LCA), neither characteristic hypergam-
maglobulinemia, nor meet the criteria for definitive diag-
nosis for autoimmune hepatitis according to the
International Autoimmune Hepatitis Group criteria or
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hepatitis published in 2008 by Hennes EM et al [6].
According with the International Autoimmune Hepati-
tis Group criteria for diagnosis of autoimmune hepati-
tis[5], the patient scored 13 points before treatment and
didn't fulfil the criteria for a definitive diagnosis of auto-
immune hepatitis (it's important to note that we didn't
test for genetic markers like HLA DR3 and HLA DR4,
which positivity could mean one point more in the score,
but not enough to fulfil the criteria).
Autoantibodies may be absent in about 10% of patients
with autoimmune hepatitis and in children the presence
of autoantibody titers tends to be lower, and may be not
detected, as in this case[2,7]. They serve as markers of
disease, but their pathogenic role and their value for fol-
low-up evaluation remains controversial [8].
Petechiae (thrombocytopenia) were the major com-
plain that brought the patient to medical attention. Based
on blood smear, bone marrow aspirate and positive anti-
platelets antibodies we presumed an immune destruction
of platelets and assumed the diagnosis of immune throm-
bocytopenia.
Idiopathic thrombocytopenia purpura is a well recog-
nized complication of viral hepatitis, but the association
between autoimmune hepatitis and immune thrombocy-
topenic purpura is not frequent, especially in children [1].
There are some case reports in literature showing this
association, but almost all were in adults [1,9-15]. Wong
T (2007) presented a case of a 10-year-old boy with auto-
immune hepatitis and a 6 month history of gingival
bleeding and epistaxis due to coagulopathy, with elevated
prothrombin time and partial thromboplastin time but
normal platelets count [11]. Our boy had also a prolonged
INR, reverted by K vitamin, but no clinical manifestations
of bleeding.
Shibuya A (2001) presented a 19 year-old woman with
typical AIH, positive serologic markers and fulfilment of
diagnostic criteria score and thrombocytopenia. Four
years later the woman developed thrombotic thrombocy-
topenic purpura and died because of multi-organic fail-
ure 9 days after the admission [9].
In 1996, Persico M described thrombocytopenia as a
sensitive marker of immunologic activity in a patient with
autoimmune chronic active hepatitis [16]. This case is a
good demonstration of it. The appearance of thrombocy-
topenia was correlated with the increasing activity of
hepatic lesion pointing to the existence of a single
pathophysiologic process. What triggers the necroin-
flammatory process of the liver, the exacerbation of the
hepatic lesion and the immune destruction of platelets
remains obscure.
Lymphadenopathy found in patient was probably a
casual association or a sequel of a past infection. Follow
up confirmed its disappearance.
In conclusion, the authors alert for the infrequent pre-
sentation and associations of this case. First, presentation
was atypical as it occurs in a male patient, (autoimmune
hepatitis is much more frequent in females) and pethe-
chiae were the sign that brought the patient to medical
attention and led to the diagnosis. Furthermore, the
patient didn't have the typical serologic markers of auto-
immune hepatitis, neither the commonly associated
hypergammaglobulinemia or fulfil the diagnostic criteria
for definitive diagnosis. Second, immune thrombocy-
topenia is not a common autoimmune disease associated
to autoimmune hepatitis and family history revealed a
strong presence of psoriasis (another autoimmune dis-
ease).
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